Vikas Peddu

This study uses long-read nanopore sequencing of cell-free RNA to detect early-stage cancer and discover novel biomarkers, identifying 270,679 intergenic RNAs and potential therapeutic targets.

This study investigates how KRAS(G12C) mutations affect transposable element RNA expression in 3D lung cancer spheroids, finding mutation-specific TE RNA dysregulation and activation of Alu-derived RNAs with innate immunity genes.

This study identifies tissue-specific RNA expression of integrated HHV-6A/B in vivo and links it to increased antibody responses against specific viral antigens.

The paper uses a consensus machine learning approach to identify gene targets associated with pediatric AML risk, finding recurrently selected genes like HOXA9 and MEIS1 across multiple algorithms.

This study uses RNA sequencing to analyze HHV-6B transcriptomes in various samples to identify diagnostic targets distinguishing latent from active infections.